Author:
Lassemillante Annie-Claude M.,Doi Suhail A. R.,Hooper John D.,Prins John B.,Wright Olivia R. L.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference65 articles.
1. C.S. Higano, Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 61(2), 32–38 (2003). doi: 10.1016/S0090-4295(02)02397-X
2. L.G. Taylor, S.E. Canfield, X.L. Du, Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 115(11), 2388–2399 (2009). doi: 10.1002/cncr.24283
3. S.L. Greenspan, P. Coates, S.M. Sereika, J.B. Nelson, D.L. Trump, N.M. Resnick, Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J. Clin. Endocrinol. Metab. 90(12), 6410–6417 (2005). doi: 10.1210/jc.2005-0183
4. S.M. Alibhai, L. Yun, A.M. Cheung, L. Paszat, Screening for osteoporosis in men receiving androgen deprivation therapy. JAMA 307(3), 255–256 (2012). doi: 10.1001/jama.2011.2022
5. National comprehensive cancer network: NCCN guidelines for prostate cancer (version 2.2014). http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf (2014). Accessed 14 Apr 2014
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献